Education, AI and More at ASH 2024
November 25, 2024 |
Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year’s programs, including a virtual patient simulation and collaborations with the Leukemia & Lymphoma Society. Additionally, Medscape will introduce new AI capabilities to enhance learning experiences for healthcare professionals, reinforcing their commitment to improving patient care through innovative education.
As the conference year draws to a close, Medscape is closing out the season in a big way, bringing 8 educational symposia and 3 posters to ASH 2024, as well as showcasing new AI capabilities.
Three posters are being presented on December 5, before the official start of the conference. In the first poster, Medscape is taking a retrospective look examining the impact of the programs produced for ASH 2023. The outcomes of this study showed how the programs made a difference in learners’ knowledge, competency, and confidence, as assessed by pre-and post-education questions. Attendees who are interested in simulation can check out Medscape’s second poster, which looks at the impact of a Medscape virtual patient simulation on cold agglutinin disease. Medscape’s third poster, on BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma, was created through the collaboration with The Leukemia & Lymphoma Society, a renowned patient advocacy group.
“It’s always so inspiring to look back at some of our education efforts over the past year and see how much of an impact they made. We’re proud to have worked with the Leukemia & Lymphoma Society to analyze and present the impact of some of our education in chronic lymphocytic leukemia and mantle cell lymphoma and show how education is making a difference,” said Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy, Medscape Oncology Global and leader of Medscape’s Patient-Integration Initiative.
The 8 educational symposia for 2024 will cover the following topics:
- Collaborating for Optimal Immune Thrombocytopenia Care: Uniting Disease, Treatment, and Patient-Centered Considerations:
- Maximizing Touchpoints to Empower Impactful Patient-Centered Care for PNH
- Guiding Our Patient’s Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-T
- Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis
- Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma
- Sharing Best Practices from the ALL/LBL Clinic: Navigating Patient-Centered Care with Asparaginase Therapies
- Clinical Assessment of Gene Therapies for Hemophilia A and Hemophilia B: Key Takeaways for Your Practice
- Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies
All symposia offer the ability to engage with the faculty as well as send notes and slides. Programs will be made available on Medscape.org following the conference.
New for 2024, Medscape will showcase AI features at their booth, allowing attendees to take a glimpse into the powerful ways Medscape is harnessing this technology to enhance education. Conference attendees are encouraged to stop by the Medscape booth during exhibitor hours to try it for themselves.
“Our AI pilot at ASH 2024 is game-changing. We’ve partnered with Erudio Health to pilot new tools that give healthcare professionals new ways to dive into content with AI chatbots and explore real-world cases. It’s not just about better learning – it’s about smarter, faster learning. We’re committed to staying ahead in medical education. Nobody understands medical education like Medscape, and we’re not just keeping up with tech – we’re leading the charge. We’re using our expertise to make AI work for our learners. This AI pilot is just the start. We’re focused on giving healthcare professionals the best learning experience out there, because better education means better patient care.” Dr Sushant Dahiya, Executive Director, Medscape Education
For more information on hematology and oncology education at Medscape, please contact Christine Carey. For more information on patient-integration, please contact Victoria Harvey-Jones, or for how we are harnessing AI to power learning with impact contact Dr Sushant Dahiya.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education and M4RD: Together Caring for Rare Disease
We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...